ASLN Aslan Pharmaceuticals
- 1.1100
- -0.2700-19.57%
- 1.1500
- +0.0400+3.60%
Aslan Pharmaceuticals News
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | F-6 POS: Post-effective amendment to a F-6EF registration
Aslan Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aslan Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aslan Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
